1199557-05-5

Basic information

• Product Name: tert-butyl 2-(4-broMophenyl)-5,8-dioxaspiro[3.4]octan-2-ylcarbaMate
• Synonyms: tert-butyl 2-(4-broMophenyl)-5,8-dioxaspiro[3.4]octan-2-ylcarbaMate
• CAS NO: 1199557-05-5
• Molecular Formula: C17H22BrNO4
• Molecular Weight: 384.26488
• EINECS: -0
• Mol File: 1199557-05-5.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 470.8±45.0 °C(Predicted)
• Appearance: /
• Density: 1.42±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 11.68±0.20(Predicted)
• CAS DataBase Reference: tert-butyl 2-(4-broMophenyl)-5,8-dioxaspiro[3.4]octan-2-ylcarbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 2-(4-broMophenyl)-5,8-dioxaspiro[3.4]octan-2-ylcarbaMate(1199557-05-5)
• EPA Substance Registry System: tert-butyl 2-(4-broMophenyl)-5,8-dioxaspiro[3.4]octan-2-ylcarbaMate(1199557-05-5)

Safety Data

• Hazardous Substances Data: 1199557-05-5(Hazardous Substances Data)

Usage

Description

Tert-butyl 2-(4-bromophenyl)-5,8-dioxaspiro[3.4]octan-2-ylcarbamate is a complex chemical compound featuring a tert-butyl group attached to a 2-(4-bromophenyl)-5,8-dioxaspiro[3.4]octan-2-ylcarbamate moiety. Its unique spirocyclic structure endows it with intriguing physical and chemical properties, suggesting potential applications in pharmacology and industry.

Uses

Used in Pharmaceutical Industry:
Tert-butyl 2-(4-bromophenyl)-5,8-dioxaspiro[3.4]octan-2-ylcarbamate is used as a building block for the synthesis of more complex molecules, potentially contributing to the development of new pharmaceutical agents. Its unique structure may offer novel pharmacological properties, making it a valuable component in drug discovery and design.
Used in Chemical Research:
In the field of chemical research, tert-butyl 2-(4-bromophenyl)-5,8-dioxaspiro[3.4]octan-2-ylcarbamate serves as an intriguing subject for further exploration. Its complex molecular structure and unique spirocyclic properties provide opportunities for studying its reactivity, stability, and potential interactions with other molecules, which could lead to new insights and applications in various chemical processes.

Upstream product

• 75-65-0 tert-butyl alcohol 

Downstream Products

• 1199556-87-0 2-[1-(4-bromophenyl)-3-oxocyclobutyl]-1H-isoindole-1,3(2H)-dione 
• 1199556-86-9 2-[2-(4-bromophenyl)-5,8-dioxaspiro[3.4]oct-2-yl]-1H-isoindole-1,3(2H)-dione 
• 1199556-88-1 2-[trans-1-(4-bromophenyl)-3-hydroxy-3-methylcyclobutyl]-1H-isoindole-1,3(2H)-dione 
• 1199556-89-2 2-[cis-1-(4-bromophenyl)-3-hydroxy-3-methylcyclobutyl]-1H-isoindole-1,3(2H)-dione 
• 1199556-90-5 2-{trans-3-hydroxy-3-methyl-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutyl}-1H-isoindole-1,3(2H)-dione 
• 1199556-40-5 trans-3-amino-3-{4-[1-(difluoromethyl)-8-phenyl-[1,2,4]triazolo[4,3-a]-1,5-naphthyridin-7-yl]phenyl}-1-methylcyclobutanol 
• 1199557-03-3 2-(trans-1-{4-[1-(difluoromethyl)-8-phenyl-[1,2,4]triazolo[4,3-a]-1,5-naphthyridin-7-yl]phenyl}-3-hydroxy-3-methylcyclobutyl)-1H-isoindole-1,3(2H)-dione 

Relevant articles and documents

INHIBITORS OF AKT ACTIVITY

The instant invention provides for compounds that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity by administering the compound to a patient in need of treatment of cancer.